Funding

Review funding opportunities and creative funding strategies to support your family-centered pregnant and postpartum women behavioral health treatment program.

Federal Funding Opportunities

  • Regional Partnership Grants to Increase the Well-Being of, and to Improve the Permanency Outcomes for, Children Affected by Substance Abuse
    Due: Monday, July 10, 2017
    These targeted grants will be awarded to regional partnerships that provide, through interagency collaboration and integration of programs and services, activities and services that are designed to increase the well-being of, improve permanency outcomes for, and enhance the safety of children who are in out-of- home placements or are at risk of entering out-of- home placements as a result of a parent's or caretaker's substance abuse. Applicants will be expected to have a collaborative structure in place that is capable of building the region's capacity to meet a broad range of needs for families involved with both substance abuse treatment and the child welfare system. More information is available here.
  • Medication-Assisted Treatment (MAT) Delivery for Pregnant Women with Substance Use Disorders Involving Prescription Opioids and/or Heroin
    Letter of Intent Deadline: July 25, 2017
    Application Deadline: October 25, 2017
    The Patient-Centered Outcomes Research Institute (PCORI) is launching this funding initiative to support patient-centered comparative clinical effectiveness research on the delivery of medication-assisted treatment (MAT) for pregnant women with Opioid Use Disorder. The study designs that PCORI will consider include large randomized controlled trials or well-justified observational studies. Through this PCORI Funding Announcement, PCORI seeks to fund studies with sufficient sample sizes to address the priority research questions. This program’s goal is to generate valid evidence that is readily generalizable to the broader population of pregnant women with OUD. More information is available here.

Other Funding Opportunities

Review these funding sources to search for other federal, regional and local opportunities to support your programs.

Funding Strategies

  • Designing Medicaid Health Homes for Individuals with Opioid Dependency: Considerations for States
    Although individuals with opioid dependency represent a small percentage of all Medicaid enrollees, they often have significant physical and behavioral health needs that result in high costs of care. States are looking for innovative, cost-effective ways to integrate and coordinate care for this high-need population. Through the Affordable Care Act, states can implement health homes to provide enhanced integration and care coordination for people with opioid dependency. This brief, made possible by the Centers for Medicare & Medicaid Services Health Home Information Resource Center, highlights key features of approved health home models from Maryland, Rhode Island, and Vermont that are tailored to individuals with opioid dependency. It identifies important considerations in developing opioid dependence-focused health homes, including: (1) leveraging opioid treatment program requirements; (2) promoting collaboration across multiple state agencies; (3) supporting providers in transforming into health homes; and (4) encouraging information sharing.
  • Health Coverage Options for Pregnant Women
    As a result of the Affordable Care Act (ACA) and the creation of health insurance exchanges, there are more coverage options for pregnant women in all states. In addition to insurance through exchanges, all states offer Medicaid coverage for pregnant women and a number of states also offer them coverage through their CHIP programs. Although there are coverage options for most pregnant women, these different coverage types do have different eligibility criteria, cost sharing and benefits. NASHP has created a few resources to help explain the different eligibility criteria for multiple coverage options, including a chart that details income eligibility for each state’s Medicaid and CHIP programs from 2013 – 2015 and maps that highlight the income eligibility ranges. NASHP also created a couple of infographics (Julie, Samantha) that note enrollment steps for pregnant women with different income seeking coverage and raise policy implications for states.
  • Using Medicaid to Finance and Deliver Services in Supportive Housing: Challenges and Opportunities
    Behavioral health authorities and community behavioral health organizations are increasingly examining ways to meet the needs of individuals with mental illnesses (MI) and/or substance use disorders (SUD). Permanent Supportive Housing (PSH) is a cost-effective, evidence-based intervention that addresses the need among many individuals, providing permanent affordable housing and community-based, person centered services. As states increase their PSH capacity, they are also seeking to leverage Medicaid as a cost-effective source to finance and deliver the services component of PSH. This paper discusses the policy context driving the inclusion of more integrated PSH options within state and local behavioral health authorities, and builds on recent federal guidance regarding Medicaid reimbursement for housing-related services. State behavioral health authorities, Medicaid agencies and organizations serving people with MI and/or SUD each play a critical role working together to identify, pay for, and implement these types of services.
  • State Medicaid Payment Approaches to Improve Access to Long-Acting Reversible Contraception
    In July 2014, the Center for Medicaid and CHIP Services (CMCS) launched the Maternal and Infant Health Initiative to improve maternal and infant health outcomes. The initiative has two primary goals: 1) increasing the rate and improving the content of postpartum visits; and 2) increasing access and use of effective methods of contraception. Medicaid provides coverage for more than 70 percent of family planning services for low-income Americans. Given this important role, CMCS sought to identify approaches to Medicaid reimbursement that promote the availability of effective contraception.1 This Informational Bulletin describes emerging payment approaches several state Medicaid agencies have used to optimize access and use of long-acting reversible contraception (LARC).
  • Early Start: A Cost-Beneficial Perinatal Substance Abuse Program
    OBJECTIVE: To conduct a cost-benefit analysis of Early Start, an integrated prenatal intervention program for stopping substance use in pregnancy. METHODS: A retrospective cohort study was conducted of 49,261 women who had completed prenatal substance abuse screening questionnaires at obstetric clinics and who had undergone urine toxicology screening tests. Four study groups were compared: women screened and assessed positive and followed by Early Start (screened-assessed-followed, n=2,032), women screened and assessed positive without follow-up (screened-assessed, n=1,181), women screened positive only (screened-positive-only, n=149), women in the control group who screened negative (control, n=45,899). Costs associated with maternal health care (prenatal through 1 year postpartum), neonatal birth hospitalization care, and pediatric health care (through 1 year) were adjusted to 2009 dollars. Mean costs were calculated and adjusted for age, race, education, income, marital status, and amount of prenatal care. RESULTS: Screened-positive-only group adjusted mean maternal total costs ($10,869) were significantly higher than screened-assessed-followed, screened-assessed, and control groups ($9,430; $9,230; $8,282; all P<.001). Screened-positive-only group adjusted mean infant total costs ($16,943) were significantly higher than screened-assessed-followed, screened-assessed, and control groups ($11,214; $11,304; $10,416; all P<.001). Screened-positive-only group adjusted mean overall total costs ($27,812) were significantly higher than screened-assessed-followed, screened-assessed, and control groups ($20,644; $20,534; $18,698; all P<.001). Early Start implementation costs were $670,600 annually. Cost-benefit analysis showed that the net cost benefit averaged $5,946,741 per year. CONCLUSION: Early Start is a cost-beneficial intervention for substance use in pregnancy that improves maternal-infant outcomes and leads to lower overall costs by an amount significantly greater than the costs of the program.
  • Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Use Disorders
    Presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. Covers treatment effectiveness and cost effectiveness as well as examples of innovative approaches in Vermont, Massachusetts, and Maryland.
  • Facilitating Cross-System Collaboration: A Primer on Child Welfare, Alcohol and Other Drug Services
    Reviews characteristics of child welfare, substance abuse services, and courts to support cross-system coordination within State, county, and tribal jurisdictions. Considers the framework, population, legislation and funding sources, and services for each system.
  • Lifting the Burden of Addiction: Philanthropic Opportunities to Address Substance Use Disorders
    Substance use disorders (SUDs), also known as substance abuse or addiction, affect an estimated 20 million or more adolescents and adults in the U.S. This guidance provides philanthropic funders with the tools & information to reduce immediate harm from substance use disorders and reduce the burden of the disorder over the long term. This includes reducing the damage the disorder causes to people with SUDs and their loved ones, reducing the overall incidence of SUDs, and reducing SUD-related costs to society. We present four strategies for philanthropic funders who want to help: - Save lives and reduce SUD-related illness and homelessness - Improve access to evidence-based treatment - Improve SUD care by changing systems and policies - Fund innovation to improve prevention and treatment.
  • Funding Family-Centered Treatment for Women with Substance Use Disorders
    This 2008 resource paper is a companion to the Family-Centered Treatment monograph and assists treatment providers and state substance abuse agencies to identify and access potential sources of funding for comprehensive family-centered treatment.